PlainRecalls
FDA Drug Moderate Class II Terminated

clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108, NDC# 68180-492-01

Reported: July 30, 2025 Initiated: June 27, 2025 #D-0537-2025

Product Description

clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108, NDC# 68180-492-01

Reason for Recall

Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.

Details

Units Affected
2,724 bottles
Distribution
Nationwide.
Location
Naples, FL

Frequently Asked Questions

What product was recalled?
clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108, NDC# 68180-492-01. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 2,724 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 30, 2025. Severity: Moderate. Recall number: D-0537-2025.